CD8A and neoplasm: The response to immune checkpoint inhibitors has been linked to a highly infiltrated and inflamed (referred to as “hot”) tumor microenvironment, which displays type I IFN activation, presence of chemokines, cytotoxic effector molecules and CD8+ T cells.